A randomized trial of risk‐adapted screening for prostate cancer in young men—Results of the first screening round of the <scp>PROBASE</scp> trial-Reference-Cited by-同舟云学术

A randomized trial of risk‐adapted screening for prostate cancer in young men—Results of the first screening round of the PROBASE trial

Published:2022-02-17 Issue:11 Volume:150 Page:1861-1869
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Intl Journal of Cancer

Author:

Arsov Christian¹,Albers Peter¹²^ORCID,Herkommer Kathleen³,Gschwend Jürgen³,Imkamp Florian⁴,Peters Inga⁴,Kuczyk Markus⁴,Hadaschik Boris⁵⁶,Kristiansen Glen⁷,Schimmöller Lars⁸,Antoch Gerald⁸,Rummeny Ernst⁹,Wacker Frank¹⁰,Schlemmer Heinz¹¹,Benner Axel¹²,Siener Roswitha¹³,Kaaks Rudolf¹⁴,Becker Nikolaus²^ORCID

Affiliation:

1. Department of Urology University Hospital, Medical Faculty, Heinrich‐Heine University Düsseldorf Düsseldorf Germany

2. Division of Personalized Early Detection of Prostate Cancer German Cancer Research Center (DKFZ) Heidelberg Germany

3. Department of Urology Technical University of Munich, School of Medicine, Klinikum rechts der Isar Munich Germany

4. Department of Urology Medical University Hannover Hannover Germany

5. Department of Urology, University Hospital Essen University of Duisburg‐Essen Duisburg Germany

6. Department of Urology, University Hospital Heidelberg Ruprecht Karls University Heidelberg Heidelberg Germany

7. Institute of Pathology, University Hospital Bonn Bonn Germany

8. Department of Diagnostic and Interventional Radiology, Medical Faculty, Duesseldorf Heinrich‐Heine University Düsseldorf Düsseldorf Germany

9. Institute of Diagnostic and Interventional Radiology, Technical University Munich Munich Germany

10. Institute of Diagnostic and Interventional Radiology, Medical University Hannover Hannover Germany

11. Department of Radiology German Cancer Research Center (DKFZ) Heidelberg Germany

12. Division of Biostatistics German Cancer Research Center (DKFZ) Heidelberg Germany

13. Department of Urology University Hospital Bonn Bonn Germany

14. Division of Cancer Epidemiology German Cancer Research Center (DKFZ) Heidelberg Germany

Funder

Deutsche Krebshilfe

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.33940

Reference27 articles.

1. Robert‐Koch‐Institut. RKI;1997.http://www.rki.de. Accessed Januray 12 2021.

2. Cancer statistics, 2020

3. A 16-yr Follow-up of the European Randomized study of Screening for Prostate Cancer

4. Association Between Lead Time and Prostate Cancer Grade: Evidence of Grade Progression from Long-term Follow-up of Large Population-based Cohorts Not Subject to Prostate-specific Antigen Screening

5. Prediction of significant prostate cancer diagnosed 20 to 30 years later with a single measure of prostate-specific antigen at or before age 50

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prostatakarzinom-Screening? Nur evidenzbasiert, risikoadaptiert und organisiert!;Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz;2024-08-05

2. Preliminary effects of risk-adapted PSA screening for prostate cancer after integrating PRS-specific and age-specific variation;Frontiers in Genetics;2024-08-01

3. Screening for Prostate Cancer with Prostate-specific Antigen;European Urology Open Science;2024-08

4. Prostate Cancer Early Detection in the European Union and UK;European Urology;2024-08

5. Prostate Cancer Screening in Young Men;Journal of Personalized Medicine;2024-07-31